Compared with their stroke-naive counterparts, CD8+ TRLs underwent genomic reprogramming after infiltration of the poststroke brain, resulting in global gene expression alterations (Figure 4A and Supplemental Table 2). The gene discussed is CD8A; the disease is stroke disorder.